Extracorporeal blood correction (hemosorption, immunoadsorption, plasmapheresis) in Henoch-Schonlein purpura in Medicana International Ankara Hospital
Medicana International Ankara Hospital
Ankara, Turkey
{"translation_price":"50","translation_doc_price":"40","child_coefficient":"1.1","transfer_price":"2.00","transfer_price_vip":"5.00","constant_transfer_price_vip":350,"constant_transfer_price":150,"constant_transfer_distanse":60,"type":"treatment","program_full_story":"<ul>\n\t<li>Initial presentation in the clinic<\/li>\n\t<li>clinical history taking<\/li>\n\t<li>review of medical records<\/li>\n\t<li>physical examination<\/li>\n\t<li>laboratory tests:\n\t<ul>\n\t\t<li>\n\t\t<div class=\"topbullet\">antinuclear antibody (ANA)<\/div>\n\t\t<\/li>\n\t\t<li>rheumatoid factor (RF)<\/li>\n\t\t<li>\n\t\t<div class=\"topbullet\">factors VIII and XIII<\/div>\n\t\t<\/li>\n\t\t<li>\n\t\t<div class=\"topbullet\">urinalysis<\/div>\n\t\t<\/li>\n\t\t<li>\n\t\t<div class=\"topbullet\">complete blood count (CBC)<\/div>\n\t\t<\/li>\n\t\t<li>\n\t\t<div class=\"topbullet\">platelet count<\/div>\n\t\t<\/li>\n\t\t<li>\n\t\t<div class=\"topbullet\">erythrocyte sedimentation rate (ESR)<\/div>\n\t\t<\/li>\n\t\t<li>\n\t\t<div class=\"topbullet\">stool guaiac test<\/div>\n\t\t<\/li>\n\t\t<li>\n\t\t<div class=\"topbullet\">blood urea nitrogen (BUN) and creatinine<\/div>\n\t\t<\/li>\n\t\t<li>\n\t\t<div class=\"topbullet\">amylase and lipase<\/div>\n\t\t<\/li>\n\t\t<li>\n\t\t<div class=\"topbullet\">electrolytes<\/div>\n\t\t<\/li>\n\t\t<li>\n\t\t<div class=\"topbullet\">plasma D-dimer<\/div>\n\t\t<\/li>\n\t\t<li>\n\t\t<div class=\"topbullet\">plasma thrombin-antithrombin (TAT) complex,<br \/>\n\t\tprothrombin fragment (PF)-1, and PF-2,<br \/>\n\t\tprothrombin time (PT) and activated partial<br \/>\n\t\tthromboplastin time (aPTT)<\/div>\n\t\t<\/li>\n\t\t<li>\n\t\t<div class=\"topbullet\">serum IgA<\/div>\n\t\t<\/li>\n\t\t<li>\n\t\t<div class=\"topbullet\">antistreptolysin O (ASO)<\/div>\n\t\t<\/li>\n\t\t<li>\n\t\t<div class=\"topbullet\">CH50<\/div>\n\t\t<\/li>\n\t\t<li>\n\t\t<div class=\"topbullet\">C3 and C4<\/div>\n\t\t<\/li>\n\t\t<li>\n\t\t<div class=\"topbullet\">immunocomplexes of IgG and IgA<\/div>\n\t\t<\/li>\n\t<\/ul>\n\t<\/li>\n\t<li>abdominal ultrasound<\/li>\n\t<li>extracorporeal blood correction<\/li>\n\t<li>nursing services<\/li>\n\t<li>treatment by chief physician and all leading experts<\/li>\n\t<li>explanation of individual treatment plan<\/li>\n<\/ul>\n<div class=\"program_required_documents mt-4\"><h4>Required documents<\/h4><ul>\n\t<li style=\"text-align: justify;\">Medical records<\/li>\n\t<li style=\"text-align: justify;\">Complete blood count (if available)<\/li>\n<\/ul>\n<\/div>","program_full_story_crm":"<ul>\n\t<li>Initial presentation in the clinic<\/li>\n\t<li>clinical history taking<\/li>\n\t<li>review of medical records<\/li>\n\t<li>physical examination<\/li>\n\t<li>laboratory tests:\n\t<ul>\n\t\t<li>\n\t\t<div class=\"topbullet\">antinuclear antibody (ANA)<\/div>\n\t\t<\/li>\n\t\t<li>rheumatoid factor (RF)<\/li>\n\t\t<li>\n\t\t<div class=\"topbullet\">factors VIII and XIII<\/div>\n\t\t<\/li>\n\t\t<li>\n\t\t<div class=\"topbullet\">urinalysis<\/div>\n\t\t<\/li>\n\t\t<li>\n\t\t<div class=\"topbullet\">complete blood count (CBC)<\/div>\n\t\t<\/li>\n\t\t<li>\n\t\t<div class=\"topbullet\">platelet count<\/div>\n\t\t<\/li>\n\t\t<li>\n\t\t<div class=\"topbullet\">erythrocyte sedimentation rate (ESR)<\/div>\n\t\t<\/li>\n\t\t<li>\n\t\t<div class=\"topbullet\">stool guaiac test<\/div>\n\t\t<\/li>\n\t\t<li>\n\t\t<div class=\"topbullet\">blood urea nitrogen (BUN) and creatinine<\/div>\n\t\t<\/li>\n\t\t<li>\n\t\t<div class=\"topbullet\">amylase and lipase<\/div>\n\t\t<\/li>\n\t\t<li>\n\t\t<div class=\"topbullet\">electrolytes<\/div>\n\t\t<\/li>\n\t\t<li>\n\t\t<div class=\"topbullet\">plasma D-dimer<\/div>\n\t\t<\/li>\n\t\t<li>\n\t\t<div class=\"topbullet\">plasma thrombin-antithrombin (TAT) complex,<br \/>\n\t\tprothrombin fragment (PF)-1, and PF-2,<br \/>\n\t\tprothrombin time (PT) and activated partial<br \/>\n\t\tthromboplastin time (aPTT)<\/div>\n\t\t<\/li>\n\t\t<li>\n\t\t<div class=\"topbullet\">serum IgA<\/div>\n\t\t<\/li>\n\t\t<li>\n\t\t<div class=\"topbullet\">antistreptolysin O (ASO)<\/div>\n\t\t<\/li>\n\t\t<li>\n\t\t<div class=\"topbullet\">CH50<\/div>\n\t\t<\/li>\n\t\t<li>\n\t\t<div class=\"topbullet\">C3 and C4<\/div>\n\t\t<\/li>\n\t\t<li>\n\t\t<div class=\"topbullet\">immunocomplexes of IgG and IgA<\/div>\n\t\t<\/li>\n\t<\/ul>\n\t<\/li>\n\t<li>abdominal ultrasound<\/li>\n\t<li>extracorporeal blood correction<\/li>\n\t<li>nursing services<\/li>\n\t<li>treatment by chief physician and all leading experts<\/li>\n\t<li>explanation of individual treatment plan<\/li>\n<\/ul>\n","is_ambulant":"0","bh_fee":"0","only_for_children":"0","no_service":"0","with_prepayment":"1","show_calculator":"1","paket_type":"1","btn_type":"2","clinic_icon":"5ffeafa65f0c5.jpg","city":"Ankara","clinic_site":"https:\/\/www.medicanainternational.com\/hospitals\/medicana-international-ankara","department_recommend":"0","country":"Turkey","country_id":"10","clinic_name":"Medicana International Ankara Hospital","cinic_name":"Medicana International Ankara Hospital","department_id":"2002","duration":"8","direction":"Hematology","min_duration":0,"clinic_id":"1423","paketPrice":"0.00","paket":"<ul>\n <li>Interpreter up to 12 hours<\/li>\n <li>Translation up to 10 pages<\/li>\n <li>Visa support<\/li>\n\n \n<\/ul>","title":"Extracorporeal blood correction (hemosorption, immunoadsorption, plasmapheresis) in Henoch-Schonlein purpura","price":{"val":13075.06,"type":"val"},"price_surcharge":0,"price_surcharge_clear":0,"extra_service_clinic":[{"id":"attendant_place","title":"Accommodation for the accompanying person ","parent":"duration","type":"count_val","val":"90.00"}],"extra_service":[],"translation_hours":"0","translation_doc_count":null,"roads":[{"id":"33","distance":"33","airport_title":"Ankara"},{"id":"32","distance":"377","airport_title":"Bursa"}],"pakets":[],"lang":{"day":"Day","days":"days","ambulatory":"Outpatient","stationaryProgram":"Inpatient"}}
Program id #
318714
Prof. Dr. med. Ender Soydan
Department of Hematology and Bone Marrow Transplantation
Specialized in: hematology, bone marrow transplantation The program includes:
- Initial presentation in the clinic
- clinical history taking
- review of medical records
- physical examination
- laboratory tests:
- antinuclear antibody (ANA)
- rheumatoid factor (RF)
- factors VIII and XIII
- urinalysis
- complete blood count (CBC)
- platelet count
- erythrocyte sedimentation rate (ESR)
- stool guaiac test
- blood urea nitrogen (BUN) and creatinine
- amylase and lipase
- electrolytes
- plasma D-dimer
- plasma thrombin-antithrombin (TAT) complex,
prothrombin fragment (PF)-1, and PF-2,
prothrombin time (PT) and activated partial
thromboplastin time (aPTT) - serum IgA
- antistreptolysin O (ASO)
- CH50
- C3 and C4
- immunocomplexes of IgG and IgA
- abdominal ultrasound
- extracorporeal blood correction
- nursing services
- treatment by chief physician and all leading experts
- explanation of individual treatment plan
Required documents
- Medical records
- Complete blood count (if available)
Service
Price from:
Type of program :
Price for 1 day:
Expected duration of the program:
The minimum duration of the program:
Select
You may also book:
Hospital directly:
Saving:
BookingHealth Price from:
About the department
The Department of Hematology and Bone Marrow Transplantation at the Medicana International Ankara Hospital, headed by Dr. Ender Soydan, is a leading private medical center in Ankara offering services of bone marrow transplantation. In the nine-bed Department, various kinds of bone marrow transplantation are performed to treat a wide range of both oncohematological and other diseases. Since December 2012, the Department is licensed by the Ministry of Health in Turkey.
Bone marrow transplantation is recommended in case of the following diseases:
- Oncohematological diseases: acute and chronic myelogenous leukemia, acute lymphoblastic leukemia, lymphoma, plasmacytoma, myelodysplasia, myelofibrosis, etc.
- Malignant tumors of different organs: breast cancer, ovarian cancer
- Immune system disorders: beta-thalassemia, immunodeficient diseases, lupus erythematosus, multiple sclerosis
- Blood diseases: aplastic anaemia, sickle-cell disease
- Brain dysplasia
- Inherited blood-formation disturbances
In general, an indication for conducting of bone marrow transplantation are such conditions, in which the patient's own hematopoietic system does not fulfil its function. For instance, in case of non-oncological diseases it will manifest itself in the form of an insufficient production of stem cells, while in case of leucosis – in production of immature stem cells.
Depending on the source of the hematopoietic cells, there are distinguished two types of the transplantation: autologous and allogenic transplantation. In the autologous transplantation technique, the patient’s own healthy stem cells are transplanted to the patient. The affected organ is removed, the patient is prescribed an intensive chemotherapy in order to kill cancerous cells. Once the preparation is completed, the transplantation can be carried out. The autologous transplantation is performed in case of malignant tumors when the tumor has not spread to the bone-marrow tissue. In the allogenic transplantation technique, the hematopoietic material of a related or unrelated donor is used. The transplanted cells of an unrelated donor must be genetically compatible with the recipient’s tissues.
Prior to the transplantation, both patient and donor have to undergo several diagnostic procedures in the Medicana Ankara Hospital in order to prevent postoperative complications. These include, inter alia, biochemical blood test, bone marrow aspiration, pneumonography, lung function test and electrocardiogram. Apart from that, additional diagnostic procedures are required to investigate the genetic compatibility.
In the Department of Hematology and Bone Marrow Transplantation at the Medicana International Ankara Hospital, the bone marrow transplantation is carried out in several stages. Once the preparation is completed, the collection of hematopoietic cells is performed. Bone marrow is harvested from the femur (of the patient or donor). The harvested material is preserved by freezing. The amount of the collected material is up to 2000 ml and depends on the weight of the patient and bone marrow concentration in the material (the lost amount will be restored in the body within a month). The bone marrow transplantation is carried out by using the infusion approach, which resembles the blood transfusion procedure. During the process of bone marrow circulation in the bloodstream, the patient is exposed to the risk of infection and bleeding. Thus, the patient is prescribed an anti-bacterial treatment, blood infusions and immunomodulatory medications (in case of an allogenic transplantation).
The specialists of the Department under the direction of Dr. Ender Soydan put a special emphasis on the rehabilitation process following bone marrow transplantation. The aim of the rehabilitation is to restore the immune system of the patient. For this purpose, it is strictly recommended to restrict communication, visiting public places as well as to wear breathing protection. In addition, patients are also recommended to get a specific vaccination against some diseases over a period of time.
The Medicana International Ankara Hospital enjoys an exceptional reputation in the field of bone marrow transplantation and regularly treats patients from Turkey and many other countries. The offered bone marrow services derive from the latest medical technologies and meet the stringent international requirements.
Photo of the doctor: (c) Medicana Health Group
About hospital
The Medicana International Ankara Hospital is one of the leading medical centers, which belongs to the largest medical network Medicana in Turkey. The hospital incorporates all specialties of the modern medicine under one roof. It particularly focuses on bone marrow transplantation, cardiology, cardiovascular surgery, medical oncology, radiation oncology, CyberKnife treatment, nuclear medicine, kidney transplantation, liver transplantation and IVF services.
With a large total indoor space (about 20,000 sq. km), 215 beds, modern architecture, high-end technology and modern quality management system, the hospital treats both Turkish citizens and many international patients. Every year, more and more patients from Europe, Russia, Northern Africa and Middle East come to Ankara to receive modern medical treatment, which meets the strictest quality standards.
A particular clinical focus is cancer treatment. The hospital has at its disposal state-of-the-art medical technologies, including, multislice CT, PET-CT, MRI ultrasound, LINAC linear accelerators capable of making IMRT, conventional and interventional radiology, nuclear medicine imaging methods and radiation oncology, which allow the physicians of the hospital to provide comprehensive diagnostics and treatment of all oncological diseases.
The hospital has brought together the best medical academic staff in the field of kidney, liver and bone marrow transplantation, etc. All employees of the hospital are constantly looking for new, clinically proven treatments in order to ensure that each patient will receive the best and most appropriate treatment in Ankara.
Photo: (c) depositphotos
Accommodation in hospital
Patients rooms
The patients of the Medicana International Ankara Hospital live in comfortable modern rooms designed in bright colors. A standard room includes an automatically adjustable bed, a bedside table, a wardrobe, a shower, a toilet, and a TV set. There is internet access in the patient rooms. The hospital also provides VIP patient rooms.
Meals and Menus
The patients of the hospital are offered a tasty, balanced three meals a day: breakfast, lunch and dinner. With appropriate indications, there may be provided a dietary or individual menu.
Further details
Standard rooms include:
Shower
Toilet
TV
Wi-Fi
